|
CREM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54360002557752E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.00060004305203E-09 |
| Normal-vs-Stage2 |
3.43329999985542E-08 |
| Normal-vs-Stage3 |
2.23239982055645E-10 |
| Normal-vs-Stage4 |
3.64230867688775E-12 |
| Stage1-vs-Stage2 |
9.679400E-01 |
| Stage1-vs-Stage3 |
2.940400E-02 |
| Stage1-vs-Stage4 |
2.22619999999951E-05 |
| Stage2-vs-Stage3 |
1.015960E-01 |
| Stage2-vs-Stage4 |
9.803900E-04 |
| Stage3-vs-Stage4 |
5.944500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56190005373702E-09 |
| Normal-vs-AfricanAmerican |
2.631900E-04 |
| Normal-vs-Asian |
1.75230052690267E-10 |
| Caucasian-vs-AfricanAmerican |
3.291600E-01 |
| Caucasian-vs-Asian |
1.466980E-01 |
| AfricanAmerican-vs-Asian |
1.291430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.53709997455331E-09 |
| Normal-vs-Female |
1.82329995546127E-09 |
| Male-vs-Female |
7.627600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.46980000392816E-08 |
| Normal-vs-Age(41-60Yrs) |
4.33230007423901E-10 |
| Normal-vs-Age(61-80Yrs) |
4.83320050648217E-10 |
| Normal-vs-Age(81-100Yrs) |
1.262200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.023500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.072100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.245800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.314000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.978600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.889180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.392100E-04 |
| Classical-VS-Follicular |
1.300970E-01 |
| Classical-VS-Other |
7.040400E-01 |
| Classical-VS-Normal |
2.74940004096891E-09 |
| Tall-VS-Follicular |
2.00129999999854E-05 |
| Tall-VS-Other |
1.928790E-01 |
| Tall-VS-Normal |
4.03954647509863E-12 |
| Follicular-VS-Other |
3.619400E-01 |
| Follicular-VS-Normal |
1.03910000048835E-07 |
| Other-VS-Normal |
1.432700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.45030045937278E-10 |
| Normal-vs-N1 |
6.36420027788631E-10 |
| N0-vs-N1 |
3.361600E-01 |
|
|
